Revolo Biotherapeutics

Revolo Biotherapeutics is developing alternative immune system therapies for long-term remission in patients with autoimmune and allergic diseases. Its two drug candidates reset the immune system by preventing chronic pro-inflammatory immune response as a result of autoimmune or allergic disease. Revolo Biotherapeutics has a global footprint with headquarters in both New Orleans and the United Kingdom.